General
Preferred name
EXATECAN
Synonyms
DX8951f ()
DX-8951f ()
Exatecan (Mesylate) ()
DX-8951 ()
DX-8951 Mesylate ()
Exatecan mesylate ()
Exatecan mesilate hydrate ()
Exatecan mesilate dihydrate ()
DX-8951F ()
Exatecan methanesulfonate dihydrate ()
P&D ID
PD072518
CAS
171335-80-1
197720-53-9
169869-90-3
Tags
available
drug candidate
drug
Drug indication
Myelodysplastic syndrome
Solid tumour/cancer
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 ¦ÌM (0.975 ¦Ìg/mL), and can be used in cancer research.
DESCRIPTION
Exatecan (DX-8951f) is a DNA topoisomerase I (TOP1) inhibitor with an IC50 value of 2.2 ??M (0.975 ??g/mL).Exatecan has antitumor activity and may be used in cancer research.
DESCRIPTION
Exatecan mesylate (DX8951f) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 ¦ÌM (0.975 ¦Ìg/mL). Exatecan mesylate can be used in cancer research.
PRICE
32
DESCRIPTION
Exatecan Mesylate (DX8951f) is a DNA topoisomerase I inhibitor (IC50: 2.2 ??M, 0.975 ??g/mL).
DESCRIPTION
Exatecan (DX-8951f) is a DNA topoisomerase I (TOP1) inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL).Exatecan has antitumor activity and may be used in cancer research.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Exatecan Mesylate (DX8951f) is a DNA topoisomerase I inhibitor (IC50: 2.2 μM, 0.975 μg/mL).
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
ReFrame library
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
52
Molecular Weight
435.16
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
2
Rotatable Bonds
1
Ring Count
6
Aromatic Ring Count
3
cLogP
2.47
TPSA
107.44
Fraction CSP3
0.38
Chiral centers
2.0
Largest ring
6.0
QED
0.45
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Topo I
Topoisomerase
Topoisomerase I
TOP1
ADC Payload
ADC Cytotoxin
MOA
Topoisomerase inhibitor
Pathway
Antibody-drug Conjugate/ADC Related
DNA Damage/DNA Repair
Cell Cycle/DNA Damage
Source data

